New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT

Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fourteen…

The post New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.